AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8379858 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 61
Study 3093704 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific refeeding protocols with enteral formulas
Number of subjects: 16
Study 30973606 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat dietary pattern
Number of subjects: 0
Study 30973606 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 29354970 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at the twelve jing-well points (20 treatments, once a day) combined with bladder function training
Number of subjects: 63
Study 29354970 — intervention group
Group type: COMPARATOR
Intervention: Routine clinical medication and bladder function training
Number of subjects: 63
Study 26463866 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid Surgery (HS)
Number of subjects: 20
Study 26463866 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical Disc Arthroplasty (CDA)
Number of subjects: 20
Study 26463866 — intervention group
Group type: COMPARATOR
Intervention: Anterior Cervical Discectomy and Fusion (ACDF)
Number of subjects: 20
Study 23305118 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute resistance training session (RT) - three sets at 60% of one-repetition maximum (1RM) with 1 minute rest between exercises and sets
Number of subjects: 27
Study 23305118 — intervention group
Group type: COMPARATOR
Intervention: Control session (CON) - seated for 30 minutes
Number of subjects: 27
Study 23305118 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute resistance training session (RT)
Number of subjects: 27
Study 21698665 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 µg of 17β-estradiol (with cyclic progesterone) transdermally for 18 months
Number of subjects: 110
Study 21698665 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental low-dose oral ethinyl-estradiol (3.75 µg daily from 0 to 6 months, 7.5 µg from 6 to 12 months, 11.25 µg from 12 to 18 months)
Number of subjects: 110
Study 21698665 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 18054621 — intervention group
Group type: EXPERIMENTAL
Intervention: ePTFE dural substitute
Number of subjects: 60
Study 18054621 — intervention group
Group type: COMPARATOR
Intervention: Standard reconstruction
Number of subjects: 60
Study 16563207 — intervention group
Group type: EXPERIMENTAL
Intervention: Illness perceptions about psychosis
Number of subjects: 100
Study 16563207 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported medication adherence
Number of subjects: 100
Study 14559846 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 185
Study 14559846 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 185
Study 11030881 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel collagen-based composite combined with autologous plasma
Number of subjects: 67
Study 11030881 — intervention group
Group type: COMPARATOR
Intervention: Collagen sponge applied with pressure (Control)
Number of subjects: 67
Study 8833315 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG biofeedback training (40 sessions of 45 minutes each over 6 months)
Number of subjects: 18
Study 8833315 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG biofeedback training
Number of subjects: 18
Study 8833315 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting list, no EEG biofeedback)
Number of subjects: 18
Study 1385295 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir (400 mg twice daily)
Number of subjects: 127
Study 1385295 — intervention group
Group type: COMPARATOR
Intervention: Isoprinosine (500 mg twice daily)
Number of subjects: 127
Study 2856766 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxprenolol
Number of subjects: 30
Study 2856766 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine
Number of subjects: 30
Study 28419217 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual coil (DC) electrodes
Number of subjects: 1077
Study 28419217 — intervention group
Group type: COMPARATOR
Intervention: Single coil (SC) electrodes
Number of subjects: 1077
Study 28330680 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening questionnaire assessing depressive symptoms (PHQ‐9) and anxiety symptoms (GAD‐7)
Number of subjects: 1837
Study 28330680 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in the trial
Number of subjects: 1837
Study 28330680 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors related to participation
Number of subjects: 1837
Study 28330680 — intervention group
Group type: COMPARATOR
Intervention: Non-responders characteristics
Number of subjects: 1837
Study 26155839 — intervention group
Group type: EXPERIMENTAL
Intervention: Interprofessional simulation-based education
Number of subjects: 0
Study 26155839 — intervention group
Group type: COMPARATOR
Intervention: Traditional course
Number of subjects: 0
Study 23527365 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-flap incision (DFI)
Number of subjects: 23
Study 23527365 — intervention group
Group type: COMPARATOR
Intervention: Conventional periosteal releasing incision (PRI)
Number of subjects: 23
Study 21034369 — intervention group
Group type: EXPERIMENTAL
Intervention: Pupil light reflex (PLR) evaluation using pupillometry with single flash stimuli of 24.6 candelas/m(2) intensity and 20 ms duration
Number of subjects: 110
Study 21034369 — intervention group
Group type: COMPARATOR
Intervention: Pupil light reflex (PLR) evaluation using pupillometry
Number of subjects: 110
Study 18444146 — intervention group
Group type: EXPERIMENTAL
Intervention: 400-mcg/day of Se
Number of subjects: 424
Study 18444146 — intervention group
Group type: COMPARATOR
Intervention: 200-mcg/day of Se
Number of subjects: 424
Study 16490580 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 25, 50, 100, 200, or 400 mg QD for 10 days
Number of subjects: 70
Study 16490580 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 800 mg on day 1 followed by 600 mg QD on days 3 to 10
Number of subjects: 70
Study 16490580 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 300 mg BID for 10 days
Number of subjects: 70
Study 16490580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 15085170 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular meal pattern (6 meals/day)
Number of subjects: 9
Study 15085170 — intervention group
Group type: COMPARATOR
Intervention: Irregular meal pattern (variable meals between 3 and 9 meals/day)
Number of subjects: 9
Study 15085170 — intervention group
Group type: EXPERIMENTAL
Intervention: Irregular meal pattern
Number of subjects: 9
Study 15085170 — intervention group
Group type: COMPARATOR
Intervention: Regular meal pattern
Number of subjects: 9
Study 11368283 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical corticosteroids (e.g., betamethasone sodium phosphate, beclomethasone dipropionate, fluticasone propionate, budesonide)
Number of subjects: 0
Study 11368283 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical corticosteroids (e.g., beclomethasone dipropionate, flunisolide, budesonide)
Number of subjects: 0
Study 11368283 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9397300 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 2121
Study 9397300 — intervention group
Group type: EXPERIMENTAL
Intervention: Ex-smokers
Number of subjects: 2121
Study 9397300 — intervention group
Group type: EXPERIMENTAL
Intervention: Never smokers
Number of subjects: 2121
Study 9397300 — intervention group
Group type: COMPARATOR
Intervention: Smokers vs Ex-smokers and Never smokers
Number of subjects: 2121
Study 9397300 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 2121
Study 7932953 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral lower extremity CUS examinations
Number of subjects: 86
Study 7932953 — intervention group
Group type: COMPARATOR
Intervention: Unilateral lower limb sonographic studies
Number of subjects: 86
Study 2458659 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 16
Study 2458659 — intervention group
Group type: COMPARATOR
Intervention: Epidural analgesia + assumed blockade of prostaglandin synthesis, blockade of receptors for histamine1, histamine2 and serotonin2, and inhibition of fibrinolysis with indomethacin, astemizole, ranitidine, ketanserin and tranexamic acid
Number of subjects: 16
Study 29289580 — intervention group
Group type: EXPERIMENTAL
Intervention: Gym-based exercise program and health coaching for 12 months
Number of subjects: 105
Study 29289580 — intervention group
Group type: COMPARATOR
Intervention: Home-based exercise program and health coaching for 12 months with telephone follow-up for the first 10 weeks
Number of subjects: 105
Study 27852382 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided lower extremity nerve block (group N)
Number of subjects: 80
Study 27852382 — intervention group
Group type: COMPARATOR
Intervention: Spinal anesthesia (group S)
Number of subjects: 80
Study 25496342 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi combined with conventional rehabilitation therapies
Number of subjects: 50
Study 25496342 — intervention group
Group type: COMPARATOR
Intervention: Standard conventional rehabilitation therapies
Number of subjects: 50
Study 22825094 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered misoprostol (400 μg vaginally or buccally 3-4 hours before IUD insertion)
Number of subjects: 108
Study 22825094 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vaginally or buccally 3-4 hours before IUD insertion)
Number of subjects: 108
Study 22825094 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered misoprostol
Number of subjects: 108
Study 22825094 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study 20560169 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive physical activity (home-based exercise on a bicycle ergometer)
Number of subjects: 62
Study 20560169 — intervention group
Group type: COMPARATOR
Intervention: Usual sedentary life (control group)
Number of subjects: 62
Study 18996858 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine (2.5 mg x kg(‐1)d(‐1)) plus low-calorie diet
Number of subjects: 61
Study 18996858 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine alone
Number of subjects: 61
Study 18996858 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 61
Study 16186076 — intervention group
Group type: EXPERIMENTAL
Intervention: black cohosh 160 mg daily
Number of subjects: 0
Study 16186076 — intervention group
Group type: EXPERIMENTAL
Intervention: multibotanical (50 mg black cohosh, alfalfa, chaste tree, dong quai, false unicorn, licorice, oats, pomegranate, Siberian ginseng, boron) four capsules daily
Number of subjects: 0
Study 16186076 — intervention group
Group type: EXPERIMENTAL
Intervention: multibotanical plus telephone counseling to increase dietary soy
Number of subjects: 0
Study 16186076 — intervention group
Group type: EXPERIMENTAL
Intervention: conjugated equine estrogen 0.625 mg +/- 2.5 mg medroxyprogesterone acetate
Number of subjects: 0
Study 16186076 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 12517545 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine sulphate (MS)
Number of subjects: 74
Study 12517545 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 74
Study 10767897 — intervention group
Group type: EXPERIMENTAL
Intervention: Records with less-than-usual intake
Number of subjects: 1090
Study 10767897 — intervention group
Group type: EXPERIMENTAL
Intervention: Records with more-than-usual intake
Number of subjects: 1090
Study 10767897 — intervention group
Group type: COMPARATOR
Intervention: Typical intake days
Number of subjects: 1090
Study 8814966 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine
Number of subjects: 24
Study 8814966 — intervention group
Group type: EXPERIMENTAL
Intervention: White wine
Number of subjects: 24
Study 8814966 — intervention group
Group type: COMPARATOR
Intervention: Grape juice (high phenols)
Number of subjects: 24
Study 8814966 — intervention group
Group type: COMPARATOR
Intervention: Grape juice (low phenols)
Number of subjects: 24
Study 1325853 — intervention group
Group type: EXPERIMENTAL
Intervention: AVP antagonist (10 micrograms/kg body weight i.v.)
Number of subjects: 21
Study 1325853 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine infusion (1.0 micrograms/kg body weight per min)
Number of subjects: 21
Study 1325853 — intervention group
Group type: EXPERIMENTAL
Intervention: AVP antagonist (5 micrograms/kg i.v.)
Number of subjects: 21
Study 1325853 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine infusion plus AVP antagonist i.v.
Number of subjects: 21
Study 6238558 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (IB) 40 micrograms four times a day
Number of subjects: 28
Study 6238558 — intervention group
Group type: COMPARATOR
Intervention: Metaproterenol (MP) 1.5 mg four times a day
Number of subjects: 28
Study 31584181 — intervention group
Group type: EXPERIMENTAL
Intervention: Cone beam computed tomography (CBCT) analysis of bony nasolacrimal canal
Number of subjects: 100
Study 31584181 — intervention group
Group type: COMPARATOR
Intervention: Gender comparison (female vs male)
Number of subjects: 100
Study 29804882 — intervention group
Group type: EXPERIMENTAL
Intervention: midazolam–alfaxalone
Number of subjects: 7
Study 29804882 — intervention group
Group type: COMPARATOR
Intervention: midazolam–ketamine
Number of subjects: 7
Study 27007793 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose spironolactone (25 mg daily)
Number of subjects: 17
Study 27007793 — intervention group
Group type: COMPARATOR
Intervention: Alternative antihypertensive regimen
Number of subjects: 17
Study 24758530 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 weeks of short one-to-one telephone calls followed by 12 weeks of group telephone calls led by a trained volunteer facilitator
Number of subjects: 70
Study 24758530 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study 21830007 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy program
Number of subjects: 50
Study 21830007 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 50
Study 20154294 — intervention group
Group type: EXPERIMENTAL
Intervention: Developmental formulations of paracetamol (acetaminophen)
Number of subjects: 25
Study 20154294 — intervention group
Group type: COMPARATOR
Intervention: Commercial products of paracetamol (acetaminophen)
Number of subjects: 25
Study 20154294 — intervention group
Group type: COMPARATOR
Intervention: All formulations (developmental and commercial)
Number of subjects: 25
Study 18316826 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1815
Study 16491770 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (group I)
Number of subjects: 15
Study 16491770 — intervention group
Group type: COMPARATOR
Intervention: Bilateral neck surgery (group II)
Number of subjects: 15
Study 12841808 — intervention group
Group type: EXPERIMENTAL
Intervention: Text + pictogram information (experimental group)
Number of subjects: 60
Study 12841808 — intervention group
Group type: COMPARATOR
Intervention: Text-only information (control group)
Number of subjects: 60
Study 10472325 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir (ACV) 15 mg/kg i.v. over one hour every 8 hours for 42 doses
Number of subjects: 10
Study 10472325 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir (VCV) 2 g every 8 hours for a total of 42 doses (after switching from ACV)
Number of subjects: 10
Study 8707374 — intervention group
Group type: EXPERIMENTAL
Intervention: ELISA test
Number of subjects: 66
Study 8707374 — intervention group
Group type: COMPARATOR
Intervention: Standard agglutination test
Number of subjects: 66
Study 1681158 — intervention group
Group type: EXPERIMENTAL
Intervention: Microscopy examination of fresh unspun and unstained urine specimens
Number of subjects: 342
Study 1681158 — intervention group
Group type: COMPARATOR
Intervention: Culture of initial urine specimens
Number of subjects: 342
Study 1681158 — intervention group
Group type: EXPERIMENTAL
Intervention: Microscopy examination of subsequent urine specimens
Number of subjects: 342
Study 1681158 — intervention group
Group type: EXPERIMENTAL
Intervention: Microscopy as a screening test
Number of subjects: 342
Study 3908330 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminum ibuprofen suspension (200 mg)
Number of subjects: 154
Study 3908330 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen with codeine elixir (240 mg and 24 mg)
Number of subjects: 154
Study 3908330 — intervention group
Group type: COMPARATOR
Intervention: All four groups (including placebo)
Number of subjects: 154
Study 3908330 — intervention group
Group type: COMPARATOR
Intervention: Placebo liquid
Number of subjects: 154
Study 30488273 — intervention group
Group type: EXPERIMENTAL
Intervention: SpineJack® (SJ)
Number of subjects: 30
Study 30488273 — intervention group
Group type: COMPARATOR
Intervention: Balloon Kyphoplasty (BKP)
Number of subjects: 30
Study 29925893 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped and collaborative care model (SCM)
Number of subjects: 737
Study 29925893 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 737
Study 26679630 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (5 capsules daily providing 2.0 g/d EPA and 1.0 g/d DHA)
Number of subjects: 0
Study 26679630 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation
Number of subjects: 0
Study 24886098 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended multi-method simulation (two week-long simulations)
Number of subjects: 84
Study 22381341 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 weeks Kirschner wire transfixion
Number of subjects: 52
Study 22381341 — intervention group
Group type: COMPARATOR
Intervention: 6 weeks Kirschner wire transfixion
Number of subjects: 52
Study 20022996 — intervention group
Group type: EXPERIMENTAL
Intervention: Body-weight-supported treadmill training (BWSTT)
Number of subjects: 15
Study 20022996 — intervention group
Group type: COMPARATOR
Intervention: Lower-extremity resistive cycling
Number of subjects: 15
Study 20022996 — intervention group
Group type: COMPARATOR
Intervention: Lower-extremity progressive, resistive strengthening
Number of subjects: 15
Study 20022996 — intervention group
Group type: COMPARATOR
Intervention: Sham condition of arm ergometry
Number of subjects: 15
Study 21093877 — intervention group
Group type: EXPERIMENTAL
Intervention: PleuraSeal (sealant group)
Number of subjects: 121
Study 21093877 — intervention group
Group type: COMPARATOR
Intervention: Control (standard lung closure only)
Number of subjects: 121
Study 15755229 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation treatment
Number of subjects: 76
Study 15755229 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet treatment
Number of subjects: 76
Study 15755229 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity treatment
Number of subjects: 76
Study 12460128 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis abuse treatment
Number of subjects: 600
Study 15512100 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether
Number of subjects: 45
Study 15512100 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether and mefloquine
Number of subjects: 45
Study 8081560 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 0
Study 8081560 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol
Number of subjects: 0
Study 2916767 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking (two standard cigarettes)
Number of subjects: 12
Study 2916767 — intervention group
Group type: COMPARATOR
Intervention: Sham smoking (unlit cigarette)
Number of subjects: 12
Study 2916767 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 12
Study 2916767 — intervention group
Group type: COMPARATOR
Intervention: Sham smoking
Number of subjects: 12
Study 29804294 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-day high-dose proton pump inhibitor triple therapy (HD-PPI-TT) with 60 mg lansoprazole, 500 mg clarithromycin, and 1 g amoxicillin, each administered twice daily for 10 days
Number of subjects: 120
Study 29804294 — intervention group
Group type: COMPARATOR
Intervention: 10-day sequential therapy (ST) with 30 mg lansoprazole and 1 g amoxicillin for 5 days followed by 30 mg lansoprazole, 500 mg clarithromycin, and 400 mg metronidazole for 5 days
Number of subjects: 120
Study 29804294 — intervention group
Group type: COMPARATOR
Intervention: 10-day sequential therapy (ST)
Number of subjects: 120
Study 29804294 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-day high-dose proton pump inhibitor triple therapy (HD-PPI-TT)
Number of subjects: 120
Study 28446253 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including motivational interviewing (MI) and psychoeducation
Number of subjects: 270
Study 28446253 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 270
Study 23241449 — intervention group
Group type: EXPERIMENTAL
Intervention: Early invitation to food supplementation (608 kcal 6 days per week)
Number of subjects: 4436
Study 23241449 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrient supplementation (MMS) (15 micronutrients)
Number of subjects: 4436
Study 23241449 — intervention group
Group type: COMPARATOR
Intervention: Usual invitation to food supplementation (around 20 weeks)
Number of subjects: 4436
Study 23241449 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-masked supplementation with either 30 mg Fe and 400 μg folic acid or 60 mg Fe and 400 μg folic acid
Number of subjects: 4436
Study 23888001 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior treatment with antipsychotic long-acting injection (LAI)
Number of subjects: 155
Study 23888001 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine (as a randomised treatment)
Number of subjects: 155
Study 23888001 — intervention group
Group type: COMPARATOR
Intervention: Non-clozapine oral SGA (as a randomised treatment)
Number of subjects: 155
Study 23888001 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch from LAI to oral antipsychotic
Number of subjects: 155
Study 21964170 — intervention group
Group type: EXPERIMENTAL
Intervention: Genomic risk information from a DTC product plus usual care
Number of subjects: 150
Study 21964170 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 150